Overview of Boron Neutron Capture Therapy in 2022.

BNCT industry BNCT manufacturer accelerator-based neutron sources boron neutron capture therapy

Journal

Cancer biotherapy & radiopharmaceuticals
ISSN: 1557-8852
Titre abrégé: Cancer Biother Radiopharm
Pays: United States
ID NLM: 9605408

Informations de publication

Date de publication:
Apr 2023
Historique:
medline: 10 4 2023
pubmed: 29 12 2022
entrez: 28 12 2022
Statut: ppublish

Résumé

In April 2022, the National Cancer Institute of the United States organized a 3-day seminar, dedicated to boron neutron capture therapy (BNCT). This short article summarizes a presentation from that event, which is intended to provide an overview of activities currently underway worldwide to make BNCT available for patient treatments. This overview does not claim to be exhaustive but shows a great deal of activity in all areas necessary for the complex therapy that is BNCT. A rapid increase in the number of BNCT centers can be expected over the next few years, coupled with the introduction of novel drugs for BNCT. It will be a major challenge to all stakeholders to create clinical networks that can conduct the necessary prospective clinical trials in a short time and in high quality.

Identifiants

pubmed: 36577026
doi: 10.1089/cbr.2022.0072
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-147

Auteurs

Wolfgang A G Sauerwein (WAG)

Deutsche Gesellschaft für Bor-Neutroneneinfangtherapie (DGBNCT), Essen, Germany.
BNCT Global GmbH, Essen, Germany.

Miha Ulčar (M)

Cosylab d.d., Ljubljana, Slovenia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH